JP2005508158A5 - - Google Patents

Download PDF

Info

Publication number
JP2005508158A5
JP2005508158A5 JP2003526332A JP2003526332A JP2005508158A5 JP 2005508158 A5 JP2005508158 A5 JP 2005508158A5 JP 2003526332 A JP2003526332 A JP 2003526332A JP 2003526332 A JP2003526332 A JP 2003526332A JP 2005508158 A5 JP2005508158 A5 JP 2005508158A5
Authority
JP
Japan
Prior art keywords
ndv
glycoprotein
strain
viral
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003526332A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005508158A (ja
Filing date
Publication date
Priority claimed from IL14539701A external-priority patent/IL145397A0/xx
Application filed filed Critical
Publication of JP2005508158A publication Critical patent/JP2005508158A/ja
Publication of JP2005508158A5 publication Critical patent/JP2005508158A5/ja
Pending legal-status Critical Current

Links

JP2003526332A 2001-09-12 2002-09-12 癌治療のための組成物および方法 Pending JP2005508158A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL14539701A IL145397A0 (en) 2001-09-12 2001-09-12 Compositions and methods for treatment of cancer
PCT/IL2002/000765 WO2003022202A2 (en) 2001-09-12 2002-09-12 Compositions and methods for treatment of cancer

Publications (2)

Publication Number Publication Date
JP2005508158A JP2005508158A (ja) 2005-03-31
JP2005508158A5 true JP2005508158A5 (cg-RX-API-DMAC7.html) 2006-01-05

Family

ID=11075779

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003526332A Pending JP2005508158A (ja) 2001-09-12 2002-09-12 癌治療のための組成物および方法

Country Status (7)

Country Link
US (2) US7223389B2 (cg-RX-API-DMAC7.html)
EP (1) EP1424897A4 (cg-RX-API-DMAC7.html)
JP (1) JP2005508158A (cg-RX-API-DMAC7.html)
AU (1) AU2002341356B2 (cg-RX-API-DMAC7.html)
CA (1) CA2458543A1 (cg-RX-API-DMAC7.html)
IL (1) IL145397A0 (cg-RX-API-DMAC7.html)
WO (1) WO2003022202A2 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2819185A1 (fr) * 2001-01-08 2002-07-12 Oreal Composition cosmetique de texture pateuse a pulverulente et son utilisation en cosmetique
WO2005113018A2 (en) 2004-04-27 2005-12-01 Wellstat Biologics Corporation Cancer treatment using viruses and camptothecins
MX2007015407A (es) * 2005-07-14 2008-02-19 Wellstat Biologics Corp Tratamiento del cancer utilizando virus, fluoropirimidinas y camptotecinas.
US20090175826A1 (en) * 2006-06-05 2009-07-09 Elankumaran Subbiah Genetically-engineered newcastle disease virus as an oncolytic agent, and methods of using same
US20100297072A1 (en) * 2009-05-19 2010-11-25 Depinho Ronald A Combinations of Immunostimulatory Agents, Oncolytic Virus, and Additional Anticancer Therapy
ATE539148T1 (de) 2009-11-30 2012-01-15 United Cancer Res Inst Neuer klon des geflügelpestvirus, herstellung und anwendung bei der medizinischen behandlung von krebs
US20120308437A1 (en) * 2009-12-14 2012-12-06 Xiaoqun Zhou Detector Module, a Method for Controlling the Detector Module and a Detection System
RU2482129C2 (ru) * 2010-11-11 2013-05-20 Никита Юрьевич Силко Штамм вируса болезни ньюкасла для создания на его основе кандидатного противоракового препарата и изучения механизмов онколизиса
WO2014011072A1 (ru) * 2012-07-11 2014-01-16 Zabelin Vladimir Arkad Evich Штамм-продуцент вируса болезни ньюкасла ndv/anas crecca/omsk/9/2010, используемый для создания на его основе кандидатного противоракового препарата
US10155991B2 (en) * 2013-08-15 2018-12-18 Xueliang James Xia Biomarkers for use in colorectal cancer
RU2562115C1 (ru) * 2014-11-13 2015-09-10 Федеральное государственное автономное образовательное учреждение высшего образования "Новосибирский национальный исследовательский государственный университет"(Новосибирский государственный университет, НГУ) Штамм вируса болезни ньюкасла для изучения онколитических свойств и механизмов онколизиса для создания прототипного противоопухолевого препарата
CN106868130B (zh) * 2014-12-24 2021-03-12 北京丽阳吉诺科技有限公司 用于结肠直肠癌中使用的生物标志物
JOP20190256A1 (ar) 2017-05-12 2019-10-28 Icahn School Med Mount Sinai فيروسات داء نيوكاسل واستخداماتها
WO2020037215A1 (en) 2018-08-17 2020-02-20 Icahn School Of Medicine At Mount Sinai Recombinant newcastle disease viruses and uses thereof for the prevention of rsv disease or human metapneumovirus disease
CN114774373B (zh) * 2022-04-27 2024-07-05 北京市农林科学院 信鸽新城疫病毒基因工程改造弱毒株及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124148A (en) * 1988-04-27 1992-06-23 United Cancer Research Institute Method for treating viral diseases with attenuated virus
US5215745A (en) * 1988-04-27 1993-06-01 United Cancer Research Institute Method for treating viral diseases with attenuated virus
US5118502A (en) * 1989-06-20 1992-06-02 The University Of Georgia Research Foundation, Inc. Naturally attenuated newcastle disease vaccine and method of using the same
DE69233158T2 (de) * 1991-03-07 2004-05-13 Connaught Technology Corp., Greenville Gentechnologisch hergestellter stamm für impfstoffe
US5602023A (en) * 1992-03-24 1997-02-11 Csatary; Laszlo K. Pharmaceutical product containing live, stabilized virus for the therapy of viral and malignant diseases and process for preparing the same
DE69435155D1 (de) * 1993-04-30 2008-12-04 Wellstat Biologics Corp Zusuammensetzungen zur Behandlung von Krebs mittels Viren
DE69632235T2 (de) * 1995-10-18 2004-08-26 Akzo Nobel N.V. Newcastle-Krankheitsvirus-Kombinationsimpfstoff
FR2749323B1 (fr) * 1996-06-04 1998-07-10 Pasteur Merieux Serums Vacc Pseudo-particules virales utiles en tant que vecteur de delivrance d'acide nucleique
FR2751225B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique aviaire
US20030044384A1 (en) * 1997-10-09 2003-03-06 Pro-Virus, Inc. Treatment of neoplasms with viruses
EP0974660A1 (en) * 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Newcastle disease virus infectious clones, vaccines and diagnostic assays
ATE500808T1 (de) * 2001-05-11 2011-03-15 Wellstat Biologics Corp Onkolytische virustherapie

Similar Documents

Publication Publication Date Title
JP2005508158A5 (cg-RX-API-DMAC7.html)
JP7141063B2 (ja) 抗原およびアジュバントとしてのインターロイキン-21を有するワクチン
JP2021121638A5 (cg-RX-API-DMAC7.html)
JPWO2021239880A5 (cg-RX-API-DMAC7.html)
CN1225685A (zh) 禽多核苷酸疫苗制剂
RU2012107671A (ru) Композиция для лечения инфекции вирусом гепатита в
JP2007509607A5 (cg-RX-API-DMAC7.html)
RU2011122615A (ru) Живой аттенуированный респираторно-синцитиальный вирус
CN105518129B (zh) 减毒流感疫苗和其用途
JP2015513897A5 (cg-RX-API-DMAC7.html)
JP2008529558A5 (cg-RX-API-DMAC7.html)
JP2010520758A5 (cg-RX-API-DMAC7.html)
Markoff et al. Sequence of the influenza A/Udorn/72 (H3N2) virus neuraminidase gene as determined from cloned full-length DNA
US6828138B1 (en) Recombinant sendai virus vector including a gene encoding a chemokine
JP2024180560A5 (cg-RX-API-DMAC7.html)
Kawano et al. Sequence determination of the hemagglutinin-neuraminidase (HN) gene of human parainfluenza type 2 virus and the construction of a phylogenetic tree for HN proteins of all the paramyxoviruses that are infectious to humans
JP2010508030A5 (cg-RX-API-DMAC7.html)
JP2008528020A (ja) 核酸構築物
JP2003503355A5 (cg-RX-API-DMAC7.html)
JP2014527526A5 (cg-RX-API-DMAC7.html)
CN102573897A (zh) 使用副粘病毒载体的经鼻喷雾型结核疫苗
US20140271564A1 (en) Vesicular stomatitis viruses containing a maraba virus glycoprotein polypeptide
JP2007516214A5 (cg-RX-API-DMAC7.html)
JPWO2020223362A5 (cg-RX-API-DMAC7.html)
EP4323516A1 (en) Signal peptides